RSV Vaccine

A Phase 3 Study to Evaluate The Efficacy, Immunogenicity, and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Subunit (Vaccine)

Sign Up For A Study

    Study Information

    Condition

    RSV Vaccine

    Phase III

    VACCINE IN ADULTS

    • Healthy volunteers
    • mRNA vaccine

    Conquest Research needs volunteers for an RSV Vaccine trial evaluating a medication designed for the prevention of Respiratory Syncytial Virus. You may qualify if you:

    • Are over 60 years old

    • Have not gotten a previous RSV vaccine

    Eligible participants will receive study-related care at no cost. Compensation for time and travel may be available. No medical insurance is required for participation.

    Sign Up For A Study

      What To Expect

      PATIENT RESOURCES & FAQ

      Conquest Research is partnering with physician practices throughout Central Florida to raise awareness and offer clinical research opportunities to those in need.

      SEE MORE
      A mature medical doctor smiling as some of his colleagues stand in the background

      Register For A Study!

      Register